Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Changes in renal and metabolic indices after switching from tenofovir disoproxil fumarate- to tenofovir alafenamide-containing ART among individuals with HIV in Canada: A retrospective study.
Shokoohi M, Gupta M, Crouzat F, Smith G, Kovacs C, Brunetta J, Chang B, Knox D, Acsai M, Merkley B, Giolma K, Fletcher D, Loutfy M. Shokoohi M, et al. Among authors: brunetta j. Int J STD AIDS. 2021 Aug;32(9):861-871. doi: 10.1177/0956462421999931. Epub 2021 Apr 23. Int J STD AIDS. 2021. PMID: 33890817
Prevalence of community-associated methicillin-resistant Staphylococcus aureus colonization in men who have sex with men.
Antoniou T, Devlin R, Gough K, Mulvey M, Katz KC, Zehtabchi M, Polsky J, Tilley D, Brunetta J, Arbess G, Guiang C, Chang B, Kovacs C, Ghavam-Rassoul A, Cavacuiti C, Corneslon B, Berger P, Loutfy MR. Antoniou T, et al. Among authors: brunetta j. Int J STD AIDS. 2009 Mar;20(3):180-3. doi: 10.1258/ijsa.2008.008243. Int J STD AIDS. 2009. PMID: 19255266
Virologic and immunologic effectiveness of tipranavir/ritonavir (TPV/r)- versus darunavir/ritonavir (DRV/r)-based regimens in clinical practice.
Antoniou T, Raboud JM, Diong C, Su D, Dewhurst N, Buckley V, Kovacs C, Rachlis A, Brunetta J, Smith G, Gough K, Fletcher D, Loutfy MR. Antoniou T, et al. Among authors: brunetta j. J Int Assoc Physicians AIDS Care (Chic). 2010 Nov-Dec;9(6):382-9. doi: 10.1177/1545109710382041. J Int Assoc Physicians AIDS Care (Chic). 2010. PMID: 21138833
Immunologic effectiveness of maraviroc- and raltegravir-containing regimens (R+M+) versus raltegravir-based regimens that do not include maraviroc (R+M-).
Antoniou T, Smith G, Su D, Raboud JM, Lee D, Kovacs C, Brunetta J, Fletcher D, Crouzat F, Loutfy M. Antoniou T, et al. Among authors: brunetta j. J Int Assoc Physicians AIDS Care (Chic). 2012 May-Jun;11(3):192-7. doi: 10.1177/1545109711424967. Epub 2012 Jan 13. J Int Assoc Physicians AIDS Care (Chic). 2012. PMID: 22247337
43 results